Filed: 11/14/2023ACC: 0001214659-23-014945
📋 What this filing means
TCG CROSSOVER MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $679.11M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$679.11M
Total AUM (reported)
87.45M
Total Shares
Allocation by class
COMM$545.37M80.3%
ADRS$133.74M19.7%
Portfolio Concentration
Top 3$180.23M26.5%
4–10$239.37M35.2%
11–25$257.14M37.9%
Rest$2.37M0.3%
Top 3 weight
26.5%
Top 10 weight
61.8%
Voting Authority Distribution
Total shares with voting rights: 87.45M
Sole
Full voting authority
87.45M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
STRUCTURE THERAPEUTICS INC
SOLEShares1.50M
TypeSH
Market value$75.77M
11.16%
Sole
1.50M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares5.63M
TypeSH
Market value$54.90M
8.08%
Sole
5.63M
Shared
0.00
None
0.00
GERON CORP
SOLEShares23.38M
TypeSH
Market value$49.56M
7.30%
Sole
23.38M
Shared
0.00
None
0.00
AN2 Therapeutics, Inc.
SOLEShares2.68M
TypeSH
Market value$43.07M
6.34%
Sole
2.68M
Shared
0.00
None
0.00
SAVARA INC.
SOLEShares10M
TypeSH
Market value$37.80M
5.57%
Sole
10M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES, INC.
SOLEShares11.11M
TypeSH
Market value$35.11M
5.17%
Sole
11.11M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS, INC
SOLEShares3.40M
TypeSH
Market value$32.70M
4.81%
Sole
3.40M
Shared
0.00
None
0.00
INHIBRX,INC
SOLEShares1.75M
TypeSH
Market value$32.12M
4.73%
Sole
1.75M
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares2.20M
TypeSH
Market value$29.87M
4.40%
Sole
2.20M
Shared
0.00
None
0.00
Icosavax, Inc.
SOLEShares3.70M
TypeSH
Market value$28.70M
4.23%
Sole
3.70M
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares3.86M
TypeSH
Market value$28.55M
4.20%
Sole
3.86M
Shared
0.00
None
0.00
VENTYX BIOSCIENCES, INC
SOLEShares815.72K
TypeSH
Market value$28.33M
4.17%
Sole
815.72K
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares1.99M
TypeSH
Market value$27.39M
4.03%
Sole
1.99M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares179.92K
TypeSH
Market value$26.28M
3.87%
Sole
179.92K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares2.10M
TypeSH
Market value$20.67M
3.04%
Sole
2.10M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS, INC.
SOLEShares1.14M
TypeSH
Market value$20.31M
2.99%
Sole
1.14M
Shared
0.00
None
0.00
RAYZEBIO, INC.
SOLEShares869.91K
TypeSH
Market value$19.31M
2.84%
Sole
869.91K
Shared
0.00
None
0.00
DYNE THERAPEUTICS, INC
SOLEShares1.65M
TypeSH
Market value$14.79M
2.18%
Sole
1.65M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares2.04M
TypeSH
Market value$13.20M
1.94%
Sole
2.04M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares1.42M
TypeSH
Market value$12.98M
1.91%
Sole
1.42M
Shared
0.00
None
0.00
IMMUNOVANT, INC
SOLEShares334.85K
TypeSH
Market value$12.86M
1.89%
Sole
334.85K
Shared
0.00
None
0.00
ENTRADA THERAPEUTICS INC
SOLEShares584.96K
TypeSH
Market value$9.24M
1.36%
Sole
584.96K
Shared
0.00
None
0.00
GRACELL BIOTECHNOLOGIES INC.
SOLEShares3.04M
TypeSH
Market value$8.75M
1.29%
Sole
3.04M
Shared
0.00
None
0.00
CABALETTA BIO, INC
SOLEShares486.80K
TypeSH
Market value$7.41M
1.09%
Sole
486.80K
Shared
0.00
None
0.00
MERUS N.V.
SOLEShares300K
TypeSH
Market value$7.07M
1.04%
Sole
300K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
STRUCTURE THERAPEUTICS INCSOLE | ADRS | 1.50M | SH | $75.77M 11.16% | 1.50M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COMM | 5.63M | SH | $54.90M 8.08% | 5.63M | 0.00 | 0.00 |
GERON CORPSOLE | COMM | 23.38M | SH | $49.56M 7.30% | 23.38M | 0.00 | 0.00 |
AN2 Therapeutics, Inc.SOLE | COMM | 2.68M | SH | $43.07M 6.34% | 2.68M | 0.00 | 0.00 |
SAVARA INC.SOLE | COMM | 10M | SH | $37.80M 5.57% | 10M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES, INC.SOLE | COMM | 11.11M | SH | $35.11M 5.17% | 11.11M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS, INCSOLE | COMM | 3.40M | SH | $32.70M 4.81% | 3.40M | 0.00 | 0.00 |
INHIBRX,INCSOLE | COMM | 1.75M | SH | $32.12M 4.73% | 1.75M | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COMM | 2.20M | SH | $29.87M 4.40% | 2.20M | 0.00 | 0.00 |
Icosavax, Inc.SOLE | COMM | 3.70M | SH | $28.70M 4.23% | 3.70M | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | ADRS | 3.86M | SH | $28.55M 4.20% | 3.86M | 0.00 | 0.00 |
VENTYX BIOSCIENCES, INCSOLE | COMM | 815.72K | SH | $28.33M 4.17% | 815.72K | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COMM | 1.99M | SH | $27.39M 4.03% | 1.99M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COMM | 179.92K | SH | $26.28M 3.87% | 179.92K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADRS | 2.10M | SH | $20.67M 3.04% | 2.10M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS, INC.SOLE | COMM | 1.14M | SH | $20.31M 2.99% | 1.14M | 0.00 | 0.00 |
RAYZEBIO, INC.SOLE | COMM | 869.91K | SH | $19.31M 2.84% | 869.91K | 0.00 | 0.00 |
DYNE THERAPEUTICS, INCSOLE | COMM | 1.65M | SH | $14.79M 2.18% | 1.65M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | COMM | 2.04M | SH | $13.20M 1.94% | 2.04M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COMM | 1.42M | SH | $12.98M 1.91% | 1.42M | 0.00 | 0.00 |
IMMUNOVANT, INCSOLE | COMM | 334.85K | SH | $12.86M 1.89% | 334.85K | 0.00 | 0.00 |
ENTRADA THERAPEUTICS INCSOLE | COMM | 584.96K | SH | $9.24M 1.36% | 584.96K | 0.00 | 0.00 |
GRACELL BIOTECHNOLOGIES INC.SOLE | ADRS | 3.04M | SH | $8.75M 1.29% | 3.04M | 0.00 | 0.00 |
CABALETTA BIO, INCSOLE | COMM | 486.80K | SH | $7.41M 1.09% | 486.80K | 0.00 | 0.00 |
MERUS N.V.SOLE | COMM | 300K | SH | $7.07M 1.04% | 300K | 0.00 | 0.00 |
Page 1 of 2